DK1152751T3 - Transdermalt, terapeutisk desoxypeganinsysstem - Google Patents
Transdermalt, terapeutisk desoxypeganinsysstemInfo
- Publication number
- DK1152751T3 DK1152751T3 DK00914071T DK00914071T DK1152751T3 DK 1152751 T3 DK1152751 T3 DK 1152751T3 DK 00914071 T DK00914071 T DK 00914071T DK 00914071 T DK00914071 T DK 00914071T DK 1152751 T3 DK1152751 T3 DK 1152751T3
- Authority
- DK
- Denmark
- Prior art keywords
- desoxypeganine
- weight percent
- transdermal
- deoxypeganine
- therapeutic
- Prior art date
Links
- WUFQLZTXIWKION-UHFFFAOYSA-N Deoxypeganine Chemical compound C1C2=CC=CC=C2N=C2N1CCC2 WUFQLZTXIWKION-UHFFFAOYSA-N 0.000 title abstract 6
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- VARHXCYGZKSOOO-UHFFFAOYSA-N Deoxyvasicinone Natural products C1=CC=C2C(=O)N(CCC3)C3=NC2=C1 VARHXCYGZKSOOO-UHFFFAOYSA-N 0.000 title 1
- 239000004902 Softening Agent Substances 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Plant Substances (AREA)
- Hydrogenated Pyridines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19906977A DE19906977C1 (de) | 1999-02-19 | 1999-02-19 | Desoxypeganin-TTS und seine Verwendung |
| PCT/EP2000/000971 WO2000048579A1 (fr) | 1999-02-19 | 2000-02-08 | Systeme therapeutique transdermique contenant de la desoxypeganine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1152751T3 true DK1152751T3 (da) | 2005-08-01 |
Family
ID=7898023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00914071T DK1152751T3 (da) | 1999-02-19 | 2000-02-08 | Transdermalt, terapeutisk desoxypeganinsysstem |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6558696B1 (fr) |
| EP (1) | EP1152751B1 (fr) |
| JP (1) | JP2002537244A (fr) |
| KR (1) | KR100674768B1 (fr) |
| AT (1) | ATE293442T1 (fr) |
| AU (1) | AU3551900A (fr) |
| DE (2) | DE19906977C1 (fr) |
| DK (1) | DK1152751T3 (fr) |
| ES (1) | ES2241588T3 (fr) |
| PT (1) | PT1152751E (fr) |
| WO (1) | WO2000048579A1 (fr) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19906979B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
| DE19906978B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit |
| DE10110953A1 (de) * | 2001-03-07 | 2002-09-19 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System zur Verabreichung von partiellen Dopamin-D2-Agonisten |
| DE10119863A1 (de) * | 2001-04-24 | 2002-11-07 | Hf Arzneimittelforsch Gmbh | Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen |
| DE10163667B4 (de) * | 2001-12-21 | 2006-10-26 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung der klinischen Depression |
| DE10305137A1 (de) * | 2003-02-07 | 2004-08-26 | Novosis Ag | Transdermale therapeutische Abgabesysteme mit einem Butenolid |
| DE10354893B4 (de) * | 2003-11-24 | 2011-03-10 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen |
| DE10354894A1 (de) * | 2003-11-24 | 2005-07-07 | Hf Arzneimittelforschung Gmbh | Orale Formulierungen des Desoxypeganins und deren Anwendungen |
| US9084803B2 (en) | 2007-06-29 | 2015-07-21 | Board Of Trustees Of Northern Illinois University | Therapeutic uses of glutathione mimics |
| US20090082436A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched rivastigmine |
| KR101317158B1 (ko) | 2011-02-18 | 2013-10-15 | 조선대학교산학협력단 | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 |
| WO2020112766A1 (fr) * | 2018-11-26 | 2020-06-04 | Steven Hoffman | Compositions et méthodes de traitement d'une exposition à des agents neurotoxiques |
| WO2020232227A1 (fr) | 2019-05-14 | 2020-11-19 | Tyme, Inc. | Compositions et méthodes de traitement du cancer |
| US10905698B1 (en) | 2020-05-14 | 2021-02-02 | Tyme, Inc. | Methods of treating SARS-COV-2 infections |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU605614A1 (ru) * | 1971-10-20 | 1978-05-05 | Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср | Антихолинэстеразное средство |
| US5336675A (en) * | 1991-05-14 | 1994-08-09 | Ernir Snorrason | Method of treating mania in humans |
| DE4301783C1 (de) * | 1993-01-23 | 1994-02-03 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil |
-
1999
- 1999-02-19 DE DE19906977A patent/DE19906977C1/de not_active Expired - Fee Related
-
2000
- 2000-02-08 US US09/889,943 patent/US6558696B1/en not_active Expired - Fee Related
- 2000-02-08 JP JP2000599371A patent/JP2002537244A/ja not_active Ceased
- 2000-02-08 AT AT00914071T patent/ATE293442T1/de not_active IP Right Cessation
- 2000-02-08 EP EP00914071A patent/EP1152751B1/fr not_active Expired - Lifetime
- 2000-02-08 DK DK00914071T patent/DK1152751T3/da active
- 2000-02-08 PT PT00914071T patent/PT1152751E/pt unknown
- 2000-02-08 AU AU35519/00A patent/AU3551900A/en not_active Abandoned
- 2000-02-08 WO PCT/EP2000/000971 patent/WO2000048579A1/fr not_active Ceased
- 2000-02-08 ES ES00914071T patent/ES2241588T3/es not_active Expired - Lifetime
- 2000-02-08 DE DE50010108T patent/DE50010108D1/de not_active Expired - Fee Related
- 2000-02-08 KR KR1020017010493A patent/KR100674768B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT1152751E (pt) | 2005-08-31 |
| US6558696B1 (en) | 2003-05-06 |
| DE19906977C1 (de) | 2000-06-15 |
| AU3551900A (en) | 2000-09-04 |
| EP1152751B1 (fr) | 2005-04-20 |
| JP2002537244A (ja) | 2002-11-05 |
| WO2000048579A1 (fr) | 2000-08-24 |
| KR100674768B1 (ko) | 2007-01-25 |
| EP1152751A1 (fr) | 2001-11-14 |
| KR20010102241A (ko) | 2001-11-15 |
| ATE293442T1 (de) | 2005-05-15 |
| DE50010108D1 (de) | 2005-05-25 |
| ES2241588T3 (es) | 2005-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU2694A (sh) | Transdermalni terapeutski sistem za odavanje galantamina | |
| DK1152751T3 (da) | Transdermalt, terapeutisk desoxypeganinsysstem | |
| CA1252361A (fr) | Dispensation transdermique de medicaments liposolubles hautement ionises | |
| BR0109107A (pt) | Usos terapêuticos de mediadores ppar | |
| SI1009393T1 (en) | Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience | |
| AU2961802A (en) | Absorbing agents and cover layer which is impermeable to active substances and which contains channel-formers or removable protective layer of a transdermal therapeutic system | |
| EP1210050B8 (fr) | Appareil pour changement de couches | |
| WO2002003969A3 (fr) | Systeme therapeutique transdermique contenant du dioxyde de silicium fortement disperse | |
| MXPA04001679A (es) | Sistema terapeutico transdermico (tt) con fentanilo como el ingrediente activo. | |
| NO992674D0 (no) | Konturen til et transdermalt terapeutisk system | |
| WO2001068060A3 (fr) | Systeme matriciel therapeutique transdermique sursature et stabilise | |
| BR9909486A (pt) | Compostos calcilìticos | |
| DE50004443D1 (de) | Wirkstoffhaltige komposition sowie deren herstellung und verwendung | |
| DK1355636T3 (da) | Transdermalt terapeutisk system til administrering af carboxylgruppeholdige, ikke-steroidale antiflogistika samt en fremgangsmåde til fremstilling deraf | |
| MXPA02009103A (es) | Sistema terapeutico transdermal para la administracion de lerisetron. | |
| DE69706070D1 (de) | Zubereitung zur perkutanen verabreichung enthaltend 6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)benzimidazol | |
| DK0379933T3 (da) | Superficielt behandlingssystem med indhold af et antineoplastisk aktivstof, især 5-fluoruracil | |
| TR200000005T2 (tr) | Sıtmaya karşı ß-alkoksiakrilatlar. | |
| CA2370023A1 (fr) | Systeme therapeutique transdermique contenant un neuroleptique tres actif | |
| ES2141548T3 (es) | Preparado farmaceutico de superficie estabilizada para su aplicacion sobre la piel. | |
| ES2188021T3 (es) | Metodo para evitar el uso indebido de un sistema terapeutico percutaneo. | |
| KR100387397B1 (fr) | ||
| TR200102732T2 (tr) | Deriye nüfuzlu tedavi sistemi ve üretim yöntemi | |
| AR022956A1 (es) | Sistema transdermal terapeutico y procedimiento para su fabricacion |